Why Shares of Athira Pharma Are Climbing Today

·2-min read
Why Shares of Athira Pharma Are Climbing Today

What happened Shares of biopharmaceutical company Athira Pharma (NASDAQ: ATHA) are up close to 13% as of 11:19 a.m. EDT on Friday after the company announced it had finished enrolling participants in its ACT-AD clinical trial for ATH-1017, a therapy for mild to moderate Alzheimer's disease.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting